Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial

Zhou, CC; Chen, GY; Huang, YC; Zhou, JY; Lin, LZ; Feng, JF; Wang, ZH; Shu, YQ; Shi, JH; Hu, Y; Wang, QM; Cheng, Y; Wu, FY; Chen, JH; Lin, XY; Wang, YS; Huang, JN; Cui, JW; Cao, LJ; Liu, YP; Zhang, YP; Pan, YY; Zhao, J; Wang, LP; Chang, JH; Chen, Q; Ren, XB; Zhang, W; Fan, Y; He, ZY; Fang, J; Gu, KS; Dong, XR; Zhang, T; Shi, W; Zou, JJ

Zhou, CC (corresponding author), Tongji Univ, Shanghai Pulm Hosp, Dept Med Oncol, Shanghai 200433, Peoples R China.

LANCET RESPIRATORY MEDICINE, 2021; 9 (3): 305

Abstract

Background Immunotherapy combined with chemotherapy has been shown to be efficacious as treatment for advanced non-squamous non-small-cell lung cancer......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索